Nanoveu is targeting three key monetisation avenues:

Nanoveu is targeting three key monetisation avenues:1. Licensing its EMASS IP to system integrators and OEMsProviding product developers with chips and pre-integrated modules, eh?3. Venturing into joint ventures in fields of medical diagnostics, smart infrastructure, and robots.These are lean, scalable models that don’t require Nanoveu to become a device manufacturer. Instead, the company provides the intelligence layer, the chip and tools that power new edge AI experiences.This approach provides instant access to the market, high margins, and broad applicability across numerous billion-dollar verticals.